Mutation profile and its correlation with clinicopathology in Chinese hepatocellular carcinoma patients. 2021

Shuo Wang, and Huasheng Shi, and Tao Liu, and Manjiang Li, and Sanshun Zhou, and Xuan Qiu, and Zusen Wang, and Weiyu Hu, and Weidong Guo, and Xiaoqian Chen, and Honglin Guo, and Xiaoliang Shi, and Junping Shi, and Yunjin Zang, and Jingyu Cao, and Liqun Wu
Liver Disease Center, Affiliated Hospital of Qingdao University, Qingdao, China.

BACKGROUND Hepatocellular carcinoma (HCC) is one of the most common causes of cancer worldwide. Although many studies have focused on oncogene characteristics, the genomic landscape of Chinese HCC patients has not been fully clarified. METHODS A total of 165 HCC patients, including 146 males and 19 females, were enrolled. The median age was 55 years (range, 27-78 years). Corresponding clinical and pathological information was collected for further analysis. A total of 168 tumor tissues from these patients were selected for next-generation sequencing (NGS)-based 450 panel gene sequencing. Genomic alterations including single nucleotide variations (SNV), short and long insertions and deletions (InDels), copy number variations, and gene rearrangements were analyzed. Tumor mutational burden (TMB) was measured by an algorithm developed in-house. The top quartile of HCC was classified as TMB high. RESULTS A total of 1,004 genomic alterations were detected from 258 genes in 168 HCC tissues. TMB values were identified in 160 HCC specimens, with a median TMB of 5.4 Muts/Mb (range, 0-28.4 Muts/Mb) and a 75% TMB of 7.7 Muts/Mb. The most commonly mutated genes were TP53, TERT, CTNNB1, AXIN1, RB1, TSC2, CCND1, ARID1A, and FGF19. SNV was the most common mutation type and C:G>T:A and guanine transformation were the most common SNVs. Compared to wild-type patients, the proportion of Edmondson grade III-IV and microvascular invasion was significantly higher in TP53 mutated patients (P<0.05). The proportion of tumors invading the hepatic capsule was significantly higher in TERT mutated patients (P<0.05). The proportion of Edmondson grade I-II, alpha fetoprotein (AFP) <25 µmg/L, and those without a history of hepatitis B was significantly higher in CTNNB1 mutated patients (P<0.05). CTNNB1 mutations were associated with TMB high in HCC patients (P<0.05). Based on correlation analysis, the mutation of TP53 was independently correlated with microvascular invasion (P=0.002, OR =3.096) and Edmondson grade III-IV (P=0.008, OR =2.613). The mutation of TERT was independently correlated with tumor invasion of the liver capsule (P=0.001, OR =3.030), and the mutation of CTNNB1 was independently correlated with AFP (<25 µmg/L) (P=0.009, OR =3.414). CONCLUSIONS The most frequently mutated genes of HCC patients in China were TP53, TERT, and CTNNB1, which mainly lead to the occurrence and development of HCC by regulating the P53 pathway, Wnt pathway, and telomere repair pathway. There were more patients with microvascular invasion and Edmondson III-IV grade in TP53 mutated patients and more patients with hepatic capsule invasion in TERT mutated patients, while in CTNNB1 mutated patients, there were more patients with Edmondson I-II grade, AFP <25 µmg/L, and a non-hepatitis B background. Also, the TMB values were significantly higher in CTNNB1 mutated patients than in wild type patients.

UI MeSH Term Description Entries

Related Publications

Shuo Wang, and Huasheng Shi, and Tao Liu, and Manjiang Li, and Sanshun Zhou, and Xuan Qiu, and Zusen Wang, and Weiyu Hu, and Weidong Guo, and Xiaoqian Chen, and Honglin Guo, and Xiaoliang Shi, and Junping Shi, and Yunjin Zang, and Jingyu Cao, and Liqun Wu
January 2022, Evidence-based complementary and alternative medicine : eCAM,
Shuo Wang, and Huasheng Shi, and Tao Liu, and Manjiang Li, and Sanshun Zhou, and Xuan Qiu, and Zusen Wang, and Weiyu Hu, and Weidong Guo, and Xiaoqian Chen, and Honglin Guo, and Xiaoliang Shi, and Junping Shi, and Yunjin Zang, and Jingyu Cao, and Liqun Wu
January 2023, Evidence-based complementary and alternative medicine : eCAM,
Shuo Wang, and Huasheng Shi, and Tao Liu, and Manjiang Li, and Sanshun Zhou, and Xuan Qiu, and Zusen Wang, and Weiyu Hu, and Weidong Guo, and Xiaoqian Chen, and Honglin Guo, and Xiaoliang Shi, and Junping Shi, and Yunjin Zang, and Jingyu Cao, and Liqun Wu
December 2012, Medical oncology (Northwood, London, England),
Shuo Wang, and Huasheng Shi, and Tao Liu, and Manjiang Li, and Sanshun Zhou, and Xuan Qiu, and Zusen Wang, and Weiyu Hu, and Weidong Guo, and Xiaoqian Chen, and Honglin Guo, and Xiaoliang Shi, and Junping Shi, and Yunjin Zang, and Jingyu Cao, and Liqun Wu
May 2019, Oncology letters,
Shuo Wang, and Huasheng Shi, and Tao Liu, and Manjiang Li, and Sanshun Zhou, and Xuan Qiu, and Zusen Wang, and Weiyu Hu, and Weidong Guo, and Xiaoqian Chen, and Honglin Guo, and Xiaoliang Shi, and Junping Shi, and Yunjin Zang, and Jingyu Cao, and Liqun Wu
March 2022, Clinics and research in hepatology and gastroenterology,
Shuo Wang, and Huasheng Shi, and Tao Liu, and Manjiang Li, and Sanshun Zhou, and Xuan Qiu, and Zusen Wang, and Weiyu Hu, and Weidong Guo, and Xiaoqian Chen, and Honglin Guo, and Xiaoliang Shi, and Junping Shi, and Yunjin Zang, and Jingyu Cao, and Liqun Wu
February 2005, World journal of gastroenterology,
Shuo Wang, and Huasheng Shi, and Tao Liu, and Manjiang Li, and Sanshun Zhou, and Xuan Qiu, and Zusen Wang, and Weiyu Hu, and Weidong Guo, and Xiaoqian Chen, and Honglin Guo, and Xiaoliang Shi, and Junping Shi, and Yunjin Zang, and Jingyu Cao, and Liqun Wu
October 2018, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology,
Shuo Wang, and Huasheng Shi, and Tao Liu, and Manjiang Li, and Sanshun Zhou, and Xuan Qiu, and Zusen Wang, and Weiyu Hu, and Weidong Guo, and Xiaoqian Chen, and Honglin Guo, and Xiaoliang Shi, and Junping Shi, and Yunjin Zang, and Jingyu Cao, and Liqun Wu
March 2005, Cancer letters,
Shuo Wang, and Huasheng Shi, and Tao Liu, and Manjiang Li, and Sanshun Zhou, and Xuan Qiu, and Zusen Wang, and Weiyu Hu, and Weidong Guo, and Xiaoqian Chen, and Honglin Guo, and Xiaoliang Shi, and Junping Shi, and Yunjin Zang, and Jingyu Cao, and Liqun Wu
November 2023, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology,
Shuo Wang, and Huasheng Shi, and Tao Liu, and Manjiang Li, and Sanshun Zhou, and Xuan Qiu, and Zusen Wang, and Weiyu Hu, and Weidong Guo, and Xiaoqian Chen, and Honglin Guo, and Xiaoliang Shi, and Junping Shi, and Yunjin Zang, and Jingyu Cao, and Liqun Wu
July 2018, Open access Macedonian journal of medical sciences,
Copied contents to your clipboard!